Tim Wilsdon is speaking during the conference in a session titled “Improving Patient Access to Innovative Cancer Therapies: The Role of Managed Entry Agreements.”
For more information on this event, click here.
An analysis of obesity diagnosis and treatment in Medicare and the associated policy landscape
Obesity is a common, serious, and costly disease that increases people’s risk for morbidity and mortality. It is characterized by abnormal or excessive body...